MobilEye Global Inc (MBLY) Stock Price Today
Aura AI Summary
Key Stats
- $6.32BMarket Cap
- 5,978,495Volume
- Consumer CyclicalSector
- $15.0252W High
- $6.5652W Low
- 15 DaysTypical Hold Time
- $4.87BEnterprise Value
- -Div Yield
- 0% Sell | 100% BuyTrading Activity
Track MobilEye Global Inc (MBLY) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, MobilEye Global Inc has traded between a low of $6.56 and a high of $15.02, highlighting its annual price range. Buy and sell MobilEye Global Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Most Recent News
FDA approves phentolamine eye drops for presbyopia, offering a new treatment for age-related near vision loss.
Opus Genetics announced FDA approval of phentolamine ophthalmic solution 0.75% for treating presbyopia, an age-related condition affecting near vision in adults. This approval, based on successful Phase 3 trials, provides a non-invasive option that i...

K2 Vision performs 5,000 Light Adjustable Lens procedures, leading globally in this advanced vision tech.
K2 Vision has completed over 5,000 procedures using the Light Adjustable Lens (LAL), making it the highest-volume practice worldwide for this technology. The LAL is unique because it can be adjusted after implantation to fine-tune vision based on the...

BlackRock's stake in Fagron drops below 3% after share transfers, holding 2.96% voting rights as of October 2026.
BlackRock, Inc. disclosed that its voting rights in pharmaceutical company Fagron NV fell below the 3% reporting threshold due to the transfer of voting securities, despite acquiring financial instruments equivalent to voting rights. As of October 12...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.